- Home
- FUTU vs AXSM Comparison
FUTU vs AXSM Comparison
Compare FUTU & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FUTU | AXSM |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | Hong Kong | United States |
| Employees | 3540 | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.7B | 12.0B |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | FUTU | AXSM |
|---|---|---|
| Price | $105.16 | $219.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 17 |
| Target Price | ★ $217.75 | $211.12 |
| AVG Volume (30 Days) | ★ 1.3M | 658.9K |
| Earning Date | 05-28-2026 | 05-04-2026 |
| Dividend Yield | ★ 3.39% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $27.96 | $57.24 |
| Revenue Next Year | $11.89 | $55.88 |
| P/E Ratio | $17.05 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $80.50 | $96.09 |
| 52 Week High | $202.53 | $260.19 |
Technical Indicators
Market Signals| Indicator | FUTU | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 39.36 |
| Support Level | $91.06 | $219.18 |
| Resistance Level | $110.18 | $236.26 |
| Average True Range (ATR) | 3.64 | 9.79 |
| MACD | 1.01 | -1.41 |
| Stochastic Oscillator | 67.66 | 5.72 |
Price Performance
Historical ComparisonAbout FUTU Futu Holdings Limited
Futu Holdings Ltd is an online broker providing one-stop online investing services.. Through its proprietary digital platforms, Futubull and Moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Group engages in online brokerage services and margin financing services. It generates its revenue in the form of brokerage commission and handling charge services, and interest income. Geographically, it operates in Hong Kong, which derives key revenue and it also has its presence in other countries.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.